GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions

(MedPage Today) — Use of GLP-1 receptor agonists was associated with a lower risk of death in cancer patients with brain metastases and type 2 diabetes, according to a retrospective cohort study. Within 3 years following a first recorded brain metastasis, patients…